Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty(®))

mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as BNT162b2 (Comirnaty(®)), have proven to be highly immunogenic and efficient but also show marked reactogenicity, leading to adverse effects (AEs). Here, we analyzed whether the severity of AEs predicts the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Jürgen, Esse, Jan, Tascilar, Koray, Steininger, Philipp, Schober, Kilian, Irrgang, Pascal, Alsalameh, Rayya, Tenbusch, Matthias, Seggewies, Christof, Bogdan, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539109/
https://www.ncbi.nlm.nih.gov/pubmed/34696171
http://dx.doi.org/10.3390/vaccines9101063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539109/
https://www.ncbi.nlm.nih.gov/pubmed/34696171
http://dx.doi.org/10.3390/vaccines9101063

Ejemplares similares